Photys Therapeutics, founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard, is advancing Phosphorylation Inducing Chimeric Small Molecules (PHICS), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/08/22 | $75,000,000 | Series A |
8VC Arkin Bio Ventures Eli Lilly and Company Heritage Medical Systems Longwood Capital Partners Mass General Brigham Ventures MPM Capital  MRL Ventures Fund Omega Funds | undisclosed |
